Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock

Intensive Care Medicine

Volumn 23, Issue 5, 1997, Pages 561-566

  Kiehl, M G ^a   Ostermann, H ^a   Meyer, J ^a   Kienast, J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Hemodynamics; L NAME; Leukocytopenia; Nitric oxide; Nitric oxide synthase inhibition; Septic shock

Indexed keywords

ADRENALIN; ARGININE METHYL ESTER; CYTOTOXIC AGENT; DOPAMINE; HYPERTENSIVE AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORFENEFRINE; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; CANCER; CLINICAL ARTICLE; ENZYME INHIBITION; FEMALE; HEART HEMODYNAMICS; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MEAN ARTERIAL PRESSURE; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE; TIME;

ADULT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; BLOOD PRESSURE; ENZYME INHIBITORS; FEMALE; HEART VENTRICLES; HEMATOLOGIC NEOPLASMS; HEMODYNAMIC PROCESSES; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; STROKE VOLUME; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 0030939321     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050373     Document Type: Article

References (31)

1. Armitage JO (1994) Bone marrow transplantation. N Engl J Med 330: 827-838
2. Lloyd-Thomas AR, Dhalinal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life threatening medical complications of hematological malignancy. Intensive Care Med 12: 317-324
3. Peters SG, Meadows JA, Gracey DR (1988) Outcome of respiratory failure in hematologic malignancy. Chest 94: 99-102
4. Brunet F, Lanore JJ, Dhainaut JF et al. (1990) Is intensive care justified for patients with haematological malignancies? Intensive Care Med 16: 291-297
5. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. BrJ Pharmacol 101: 746-752
6. Gardiner SM, Compton AM, Kemp PA, Bennett T (1990) Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol 101: 632-639
7. Schini VB, Vanhoutte PM (1993) Role of L-arginine-nitric oxide pathway in vascular smooth muscle. Eur Heart J 14: 16-21
8. Szabo C (1995) Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 3: 2-32
9. Neilly IJ, Copland M, Haj M, Adey G, Benjamin N, Bennett B (1995) Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia. Br J Haematol 89: 199-202
10. Doughty LA, Kaplan SS, Carcillo JA (1996) Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 24: 1137-1143
11. Preiser JC, Lejeune P, Roman A et al. (1995) Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23: 259-264
12. Lorente JA, Landin L, DePablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287-1295
13. Schilling J, Cakmakci M, Battig U, Geroulanos S (1993) A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase. Intensive Care Med 19: 227-231
14. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28: 34-39
15. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874
16. Armitage P, Berry G (1987) Statistical methods in medical research. Blackwell, Oxford
17. Hollenberg SM, Cunnion RE, Zimmerberg J (1993) Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264:H660-H663
18. Meyer J, Traber LD, Nelson S et al. (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73: 324-328
19. Meyer J, Lentz, CW, Stothert JC, Traber LD, Herndon DN, Traber DL (1994) Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 22: 306-312
20. G-Methyl-L-arginine in vasopressor-refractory septic shock. Intensive Care Med 21:S6
21. Gomez-Jimenez J, Salgado A, Mourelle M et al. (1995) L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23: 253-257
22. Vincent JL, Colice G, Grover R, Zaccardelli D, Guntupalli K, Watson D (1995) The effects of 546C88 on left ventricular performance in patients with septic shock. Intensive Care Med 21:S20
23. Balligand JL, Ungureanu D, Simmons WW et al. (1994) Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 269: 27580-27588
24. Finkel MS, Oddis CV, Mayer OH, Hattier BG, Simmons RL (1995) Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther 72: 945-952
25. Kanwar S, Kubes P (1995) Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz 3: 93-104
26. Balligand JL, Ungureanu D, Kelly RA et al. (1993) Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314-2319
27. Locker GJ, Burgmann H, Staudinger T, Knapp S, Laczika KF, Frass M (1996) Fatal side effects of L-NMMA? Crit Care Med 24: 1930
28. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA, Pruitt BA Jr (1994) Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129: 149-155
29. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM (1994) Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129: 142-147
30. Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, Stewart DJ (1995) Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 15: 52-57
31. Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW (1996) Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 24: 1219-1225